41
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
May 31, 2026
2150407
176282
2
Public Timelines
FAQ

may 23, 2017 - Pembrolizumab Approved

Description:

FDA approved Pembrolizumab for specific tumors which have been identified to have a biomarker referred to as microsatellite instability-high. Meant for those who have undergone other treatments, and with no other alternatives.

Added to timeline:

15 Nov 2018
0
0
367

Date:

may 23, 2017
Now
~ 9 years ago